FDA Expands Nevisense Use to More Healthcare Professionals in the U.S.
SciBase has received FDA approval to expand the labeling of its AI-based skin diagnostic tool, Nevisense, allowing physician assistants and medical assistants to perform the procedure under dermatologist supervision.